Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 87 total PSOs listed by AHRQ.

PLEASE NOTE: To search for a PSO by State, use the 2 letter state abbreviation. Example: Kansas = KS

Academic Medical Center (AMC) PSO - P0103
Component of Parent Org(s):
  • Risk Management Foundation of the Harvard Medical Institutions, Inc.
Effective Date and Time of Initial Listing: December 22, 2010 12:01 AM ET
PSO Mailing Address: c/o CRICO/RMF, 1325 Boylston Street, Boston, MA 02215
PSO Phone Number: 617-450-5586
Web Site: https://www.rmf.harvard.edu/Products-and-Services/AMC-PSO-home-page
Point of Contact: Joanne Locke
Point of Contact Phone: 617-450-6873
Point of Contact Email: jlocke2@rmf.harvard.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/22/2018 through 12/21/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
CHS PSO, LLC - P0122
Component of Parent Org(s):
  • CHS/Community Health Systems, Inc.
Effective Date and Time of Initial Listing: January 11, 2012 12:01 AM ET
PSO Mailing Address: 4000 Meridian Boulevard, Franklin, TN 37067
PSO Phone Number: (615) 465-7000
Point of Contact: Terrie Van Buren RN, BSN, MBA, CPPS
Point of Contact Phone: 615-465-7518
Point of Contact Email: terrie_vanburen@chs.net (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 01/11/2020 through 01/10/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
ECRI Institute PSO - P0008
Component of Parent Org(s):
  • ECRI Institute
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 5200 Butler Pike, Plymouth Meeting, PA 19462
PSO Phone Number: 866-247-3004
Web Site: https://www.ecri.org/solutions/patient-safety-organization/
Point of Contact: Sheila Rossi MHA
Point of Contact Phone: (610) 825-6000, ext. 5281
Point of Contact Email: srossi@ecri.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2018 through 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
HCA Patient Safety Organization, LLC - P0157
Component of Parent Org(s):
  • HCA Holdings, Inc. (direct parent: EP Holdco, LLC)
Effective Date and Time of Initial Listing: April 9, 2014 12:01 AM ET
PSO Mailing Address: P.O. Box 750, Nashville, TN 37202
PSO Phone Number: (615) 344-2293
Point of Contact: Sharon Weidner Hickman
Point of Contact Phone: 615-344-1254
Point of Contact Email: Sharon.Hickman@hcahealthcare.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/09/2018 through 04/08/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Kentucky Institute for Patient Safety & Quality - P0022
Component of Parent Org(s):
  • Kentucky Hospital Association
Effective Date and Time of Initial Listing: November 26, 2008 12:01 AM ET
PSO Mailing Address: P.O. Box 436629, Louisville, KY 40253
PSO Phone Number: (502) 426-6220
Web Site: http://www.kipsq.org
Point of Contact: Nancy C. Galvagni
Point of Contact Phone: (502) 426-6220
Point of Contact Email: ngalvagni@kyha.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/26/2018 through 11/25/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Midwest Alliance for Patient Safety - P0087
Component of Parent Org(s):
  • Illinois Health and Hospital Association
Effective Date and Time of Initial Listing: April 28, 2010 12:01 AM ET
PSO Mailing Address: 1151 East Warrenville Road, Naperville, IL 60566
PSO Phone Number: 630-276-5682
Web Site: http://www.Alliance4PTSafety.org
Point of Contact: Carrie Pinasco
Point of Contact Phone: 630-276-5845
Point of Contact Email: cpinasco@team-iha.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/28/2020 through 04/27/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Nebraska Coalition for Patient Safety - P0076
Component of Parent Org(s):
  • Nebraska Academy of Physician Assistants
  • Nebraska Hospital Association
  • Nebraska Medical Association
  • Nebraska Nurses Association
  • Nebraska Pharmacists Association
  • Nebraska Pharmacists' Association
Effective Date and Time of Initial Listing: October 14, 2009 12:01 AM ET
PSO Mailing Address: 986055 Nebraska Medical Center, Omaha, NE 68198-6055
PSO Phone Number: 402-559-8421
Web Site: http://www.nepatientsafety.org/
Point of Contact: Gail E Brondum LPN
Point of Contact Phone: 402-559-8421
Point of Contact Email: gail.brondum@unmc.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/14/2019 through 10/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
UHS Acute Care PSO - P0110
Component of Parent Org(s):
  • UHS of Delaware, Inc.
Effective Date and Time of Initial Listing: April 22, 2014 12:01 AM ET
PSO Mailing Address: 367 South Gulph Road, King of Prussia, PA 19406
PSO Phone Number: (610) 382-3385
Point of Contact: Heidi Speirs
Point of Contact Phone: (610) 382-1057
Point of Contact Email: heidi.speirs@uhsinc.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/22/2018 through 04/21/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes